MIRAMIRA PHARMACEUTICALS, INC.vs its industry peers
A metric-by-metric comparison of MIRA PHARMACEUTICALS, INC. against SIC 2834 — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| Company | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MIRAThis | $21M#8 | — | 2.6x#11 | — | — | -33.0%#11 | — | -127.9%#11 | — | — | -69.7%#5 | — |
| ABVC | $28M#1 | — | 2.7x#12 | 93.2x#12 | 0.0%#3 | -61.3%#15 | -2416.0%#11 | -76.9%#7 | -68.5%#6 | — | — | — |
| CELU | $27M#2 | — | — | 1.0x#2 | -51.0%#7 | -58.4%#14 | -230.9%#4 | — | -260.7%#9 | — | — | — |
| CPHI | $27M#3 | — | 0.7x#4 | 6.4x#6 | -8.5%#5 | 32.7%#6 | -78.2%#2 | -8.8%#3 | -7.7%#2 | 5#1 | — | — |
| NXTC | $26M#4 | — | 2.2x#10 | 1.2x#3 | 252.6%#1 | -0.3%#7 | -257.5%#5 | -459.7%#13 | — | — | — | — |
| CRVO | $25M#5 | 0.0x#1 | 1.1x#8 | 6.2x#5 | -58.9%#8 | -65.6%#16 | -706.2%#8 | -117.5%#10 | -5165.9%#10 | — | — | — |
| SHPH | $24M#6 | 0.1x#2 | 1.3x#9 | — | — | -28.2%#10 | — | -61.1%#6 | -62.1%#5 | — | — | — |
| ATOS | $24M#7 | — | 0.9x#6 | 13623.6x#13 | -95.6%#11 | -36.3%#13 | -2112684.9%#13 | -129.6%#12 | — | — | -82.0%#6 | — |
| AYTU | $21M#9 | — | 0.6x#3 | 0.4x#1 | -13.3%#6 | -5.1%#8 | -14.4%#1 | -40.5%#4 | -43.8%#4 | 4#3 | — | — |
| TXMD | $21M#10 | — | 0.8x#5 | 6.9x#7 | 71.6%#2 | 73.9%#3 | -145.3%#3 | -2.1%#2 | -3.8%#1 | 5#1 | 50.0%#1 | — |
| IGC | $21M#11 | — | 3.4x#13 | 16.3x#9 | -5.5%#4 | 45.2%#5 | -585.8%#7 | -116.1%#9 | -125.5%#8 | 3#4 | -49.6%#3 | — |
| COCP | $19M#12 | — | 18.5x#14 | 9.6x#8 | -69.3%#9 | 49.5%#4 | -447.8%#6 | -845.9%#14 | -20.4%#3 | 3#4 | -10.7%#2 | — |
| MCRB | $19M#13 | — | 0.5x#2 | 23.9x#10 | — | 4088.2%#1 | -11910.1%#12 | 16.5%#1 | -72.9%#7 | — | -88.4%#7 | — |
| KYNB | $18M#14 | 0.1x#3 | — | 2.8x#4 | -78.3%#10 | 485.6%#2 | -712.7%#9 | — | — | — | -58.2%#4 | — |
| CNTX | $18M#15 | — | 0.5x#1 | — | — | -35.2%#12 | — | -94.6%#8 | — | — | — | — |
| ELAB | $18M#16 | — | 1.1x#7 | 29.9x#11 | — | -24.0%#9 | -1304.4%#10 | -46.3%#5 | — | — | — | — |
Peer set: US filers sharing this company's SEC industry classification (SIC 2834). SIC is coarse — conglomerates and multi-segment companies map imperfectly. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Some peers are still being computed, so this table covers part of the group and ranks are within the rows shown; it fills in shortly. This table timed out mid-build, so it covers part of the group; ranks are within the rows shown and it fills in shortly. Table built 2026-11-03.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice